SEC Form 4Coverage since Jul 2, 2026
$BCYC insider trading
Over the last 12 months, Bicycle Therapeutics insiders reported no purchases and 5 sales totaling $60K across SEC Form 4 filings. 20% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $60K 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 20% pre-arranged plans
Side
Price · $BCYC · 12Mvia TradingView
Top insiders · 12m
Thompson Travis AlvinChief Financial Officer1× · $4K
Perry Jennifer ScottChief Operating Officer1× · $6K
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF1× · $8K
Skynner MichaelCHIEF SCIENTIFIC OFFICER1× · $10K
Lee KevinCHIEF EXECUTIVE OFFICER1× · $33K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Perry Jennifer ScottChief Operating Officer · O | ▼ Sale | 1,412 | $4.29 | $6K | -1.5% | plan · 3 tranches |
| Jul 6, 2026 | Skynner MichaelCHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 2,391 | $4.28 | $10K | -1.5% | 2 tranches |
| Jul 6, 2026 | Lee KevinCHIEF EXECUTIVE OFFICER · O·D | ▼ Sale | 7,642 | $4.28 | $33K | -1.3% | 2 tranches |
| Jul 6, 2026 | Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF · O | ▼ Sale | 1,761 | $4.28 | $8K | -1.8% | 2 tranches |
| Jul 6, 2026 | Thompson Travis AlvinChief Financial Officer · O | ▼ Sale | 923 | $4.27 | $4K | -1.4% | 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BCYC feed.